The adaptive immune system is highly sensitive to arrayed antigens, and multivalent display of viral glycoproteins on symmetric scaffolds has been found to substantially increase the elicitation of antigen-specific antibodies. Motivated by the considerable promise of this strategy for next-generation anti-viral vaccines, we set out to design new self-assembling protein nanoparticles with geometries specifically tailored to scaffold ectodomains of different viral glycoproteins. We first designed and characterized homo-trimers from designed repeat proteins with N-terminal helices positioned to match the C termini of several viral glycoprotein trimers. Oligomers found to experimentally adopt the designed configuration were then used to generate nanoparticles with tetrahedral, octahedral, or icosahedral symmetry. Examples of all three target symmetries were experimentally validated by cryo-electron microscopy and several were assessed for their ability to display viral glycoproteins via genetic fusion. Electron microscopy and antibody binding experiments demonstrated that the designed nanoparticles display conformationally intact native-like HIV-1 Env, influenza hemagglutinin, and prefusion RSV F trimers in the predicted geometries. This work demonstrates that novel nanoparticle immunogens can be designed from the bottom up with atomic-level accuracy and provides a general strategy for precisely controlling epitope presentation and accessibility.
Introduction
Multivalent antigen display, in which antigen is presented to the immune system in a repetitive array, has been demonstrated to increase the potency of humoral immune responses 1, 2 . This has been attributed to increased cross-linking of antigen-specific B cell receptors at the cell surface and modulation of the immunogen trafficking to and within lymph nodes 3, 4 . An ongoing challenge has been to develop multimerization platforms capable of presenting complex oligomeric or engineered antigens [5] [6] [7] , as these can be difficult to stably incorporate into non-protein-based nanomaterials (e.g. liposomes, polymers, transition metals and their oxides). Attributes such as epitope accessibility, proper folding of the antigen, and overall stability are additional considerations that must be taken into account in any design strategy for antigen presentation. Several reports have utilized non-viral, naturally occurring protein scaffolds, such as self-assembling ferritin [8] [9] [10] , lumazine synthase 5, 11 , or encapsulin 12 nanoparticles, to present a variety of complex oligomeric or engineered antigens. These studies collectively highlight several of the key advantages of using self-assembling proteins as scaffolds for multivalent antigen presentation 13, 14 , including the formation of stable, highly monodisperse immunogens, the existence of scalable manufacturing methods, and seamless integration of antigen and scaffold via genetic fusion. More recently, computationally designed one- 15 and two- 16, 17 component protein nanoparticles have also been used to present complex oligomeric antigens 18, 19 . The high stability of designed proteins 20, 21 , versatility and ease of production and purification, increased potency observed upon immunization 18, 19 , and the ability to predictively explore new structural space make these materials attractive as scaffolds for multivalent antigen presentation.
Despite this progress, control over the structure of nanoparticle immunogens has remained incomplete, limiting the potential of structure-based vaccine design. Even in the reported cases where computationally designed nanoparticles were used as scaffolds, the nanoparticle subunits were derived from naturally occurring oligomeric proteins.
Nanoparticle scaffolds specifically designed from the bottom up for multivalent display of antigens of interest could be still more effective. For example, for scaffolding homooligomeric class I viral fusion proteins, a large group that includes many important vaccine antigens 22 , designed nanoparticles with a close geometric match between the C termini of the antigen and the N termini of the scaffold would provide considerable advantages.
First, the antigen could be displayed without structural distortion near its base, potentially allowing for better retention of epitopes relevant to protection. Second, they could enable the multivalent display of antigens for which no compatible nanoparticle scaffolds are currently available. More broadly, by allowing atomically precise control over the geometry of antigen presentation, bottom up design of novel nanoparticle scaffolds would enable systematic investigation of the structural determinants of immunogenicity.
Results

Method overview
We sought to develop a general computational method for generating de novo protein nanoparticles with geometries tailored to display specific antigens of interest, focusing in particular on the challenge of displaying the pre-fusion conformations of the trimeric viral glycoproteins HIV-1 Env (BG505 SOSIP) 23, 24 , influenza hemagglutinin (H1 HA) 25 , and respiratory syncytial virus (RSV) F (DS-Cav1) 7 . To make the tailored nanoparticle design problem computationally tractable, we used a hierarchical approach.
First, monomeric protein building blocks were docked into trimeric homo-oligomers with cyclic symmetry (Figure 1a ) and computationally screened for configurations featuring N termini with spacings similar to the C termini of the corresponding antigen ( Figure 1b ). Rosetta combinatorial sequence design was then used to generate energetically favorable protein-protein interfaces between the monomeric subunits. Upon experimental characterization, trimers found to self-assemble into the desired structure were then paired with second oligomeric components as building blocks for two-component nanoparticle docking in tetrahedral, octahedral, or icosahedral symmetry as previously described ( Figure 1c ) 16, 17 . Rosetta sequence design was employed to optimize interactions between the oligomers, generating secondary designed interfaces to drive nanoparticle assembly. This step-wise computational design protocol yielded twocomponent nanoparticles tailored to present 4, 8, or 20 trimers of viral glycoprotein antigens ( Figure 1d ). These steps are described in detail in the following sections.
In silico symmetric docking and trimeric antigen targeting
A topologically diverse set of stable designed repeat proteins was used as scaffolds for symmetric trimer design, restricting trimeric configurations to those compatible with genetic fusion to at least one of the BG505 SOSIP, H1 HA, or DS-Cav1 trimers (see Methods). These viral fusion proteins were selected because of their importance as vaccine antigens, the availability of high-resolution structural data, and the variety they present in C-terminal geometry (31 nm, 15 nm, and 8 nm C-terminal separation distance for each glycoprotein, respectively). C3-symmetric docks of individual repeat proteins were rapidly assessed by the previously described RPX scoring method, which identifies arrangements likely to have good side chain packing 26 . Top-scoring docked configurations with an RPX score above 5.0 were computationally screened for termini geometries compatible with fusion to any of the three selected antigens using the previously described sic_axle protocol 18 . Geometrically compatible docks (those with non-clashing termini separation distances of 15 Å or less) were subjected to full Rosetta C3-symmetric interface design and filtering (see Methods) 26 , and 23 designs were selected for experimental characterization (design strategy presented in Supplementary   Figure 1 ; sequences for all trimer designs are in Supplementary Table 7 ).
Structural characterization of designed trimers
Synthetic genes encoding each of the designed trimers were expressed in E. coli and the resulting proteins purified from lysates by Ni 2+ immobilized metal affinity chromatography (Ni 2+ IMAC) followed by size-exclusion chromatography (SEC). 21 designs were found to express in the soluble fraction, and 11 formed the intended Table 2; SEC chromatograms for remaining designs with off-target retention volumes are in Supplementary Figure 3 ). 4 of the designs that were trimeric and expressed well were selected for solution small angle X-ray scattering (SAXS) experiments and displayed scattering profiles very similar to those computed from the corresponding design model ( Figure 2 top panel, third row; metrics in Supplementary Table 1 and 3), suggesting similar supramolecular arrangement, and these were carried forward into crystallization screens.
Crystals were obtained for two designs, and structures of 1na0C3_2 and 3ltjC3_1v2 were determined at 2.6 and 2.3 Å resolution, revealing a heavy-atom R.M.S.D. between the design model and structure of each trimer at 1.4 and 0.8 Å, respectively. The structures confirmed in both cases that the designed proteins adopt the intended trimeric configurations, and that most of the atomic details at the trimeric interfaces are recapitulated as designed. Crystallization conditions, structure metrics, and structure-to-model comparisons are described in the Supplementary Methods, Supplementary Figure   4 ,
and Supplementary  Table  4 .
Generation of two-component nanoparticles from designed trimers
Each SAXS-validated trimer (Figure 2a -d) was docked pairwise with a set of previously designed symmetric homo-oligomers 26 to generate tetrahedral, octahedral, and icosahedral arrangements using the TCdock program 16, 17 . Icosahedral designs are particularly interesting as vaccine scaffolds as they have the highest valency among the cubic point group symmetries (20 trimers per particle compared to 8 for octahedra and 4 or 8 for tetrahedra), and higher valency has been shown to elicit higher antibody (Ab) titers in immunization studies 18, 19, 27 . To increase the probability of generating icosahedra, three naturally occurring homopentamers were also included in the docking calculations (PDB IDs 2JFB, 2OBX, and 2B98; sequences in Supplementary Table 7 ). To identify configurations likely to have a high number of energetically favorable side chain contacts following Rosetta interface design, nanoparticle docks were scored and ranked using the RPX method 26 . High-scoring and non-redundant nanoparticle configurations in which the N-terminal antigen fusion sites faced outward were selected for Rosetta interface design.
The models with the best overall metrics for each unique docked configuration were then selected for experimental characterization (see Methods). The names of the 11 tetrahedra, 21 octahedra, and 21 icosahedra selected indicate, in order, the symmetry of the nanoparticle (T, O, or I), the oligomeric state of the first component (A), that of the second component (B), the letters "dn" reflecting the de novo origin of the input oligomers, and the rank by RPX score from the docking stage (e.g., "I53_dn5" indicates an icosahedral nanoparticle constructed from pentameric and trimeric components, ranked 5th in RPX-scoring). Sequences and input oligomer combinations for each designed nanoparticle are listed in Supplementary Table 8 .
Synthetic genes encoding each of the 53 two-component nanoparticles were obtained and the designs were purified using Ni 2+ IMAC (see Supplementary Methods) .
Pairs of proteins at the expected molecular weights were found to co-elute by SDS-PAGE Figure 10 ).
Structural Characterization of Designed Nanoparticles
The five SAXS-validated nanoparticles were structurally characterized using negative stain electron microscopy (NS-EM) 29, 30 . 2,000-5,000 particles were manually picked from the electron micrographs acquired for each designed nanoparticle and classified in 2D using the Iterative MSA/MRA algorithm (see Supplementary Methods).
3D classification and refinement steps were performed in Relion/3.0 31 . Analysis of the NS-EM data confirmed high sample homogeneity for all 5 nanoparticle designs as evident from the micrographs and 2D class-averages ( Figure 3 ). Free nanoparticle components were detected in the T33_dn5 sample, suggesting a certain propensity towards disassembly ( Figure 3b ). Analysis of the reconstructed 3D maps revealed that all 5 nanoparticles assemble as predicted by the design models, at least to the resolution limits of NS-EM.
In order to obtain higher-resolution information, three nanoparticles, T33_dn10, O43_dn18, and I53_dn5, representing one of each targeted symmetry in the design stage (T, O, I), were subjected to cryo-electron microscopy (cryo-EM). Cryo-EM data acquisition was performed as described in the Methods section and data acquisition statistics are displayed in Supplementary Table 5 . The data processing workflow is presented in Table 1 ).
Characterization of Viral Glycoprotein-Nanoparticle Fusions
To explore the capability of the designed nanoparticles to display viral glycoproteins, we first generated fusions of a stabilized version of the BG505 SOSIP trimer to trimeric components of the nanoparticles. Synthetic genes for BG505 SOSIP fused to the N termini of T33_dn2A, T33_dn10A, and I53_dn5B (BG505 SOSIP-T33_dn2A, BG505 SOSIP-T33_dn10A, and BG505 SOSIP-I53_dn5), were transfected into HEK293F cells (see Supplementary Methods; sequences in Supplementary Table   9 ). The secreted fusion proteins were then purified using a combination of immuno-affinity chromatography and SEC. The second component for each nanoparticle was produced recombinantly in E. coli as described above for the designed trimers, and in vitro assembly reactions were prepared with equimolar mixtures of the two components and incubated overnight (see Supplementary Methods) .
Assembled nanoparticles were purified by SEC and analyzed by NS-EM as described in the Methods section to assess particle assembly and homogeneity. ~1,000 particles were manually picked and used to perform 2D classification and 3D classification/refinement in Relion 31 . Reconstructed 3D maps with docked nanoparticle (cyan for fusion component and gray for assembly component) and BG505 SOSIP trimer (green) models are displayed in Figure 5 (left). BG505 SOSIP trimers are clearly discernible in 2D class-averages and reconstructed 3D maps. However, the trimers appear less well-resolved than the corresponding nanoparticle core in the three reconstructions, likely due to the short flexible linkers between the BG505 SOSIP trimer and the trimeric nanoparticle components (sequences in Supplementary Table 9 ). The self-assembling cores of the antigen-bearing T33_dn2, T33_dn10, and I53_dn5 nanoparticles were very similar to the NS-EM maps of the unmodified nanoparticles (at least to the resolution limits of NS-EM), demonstrating that fusion of the BG505 SOSIP trimer did not induce any major structural changes to the underlying nanoparticle scaffolds.
To further characterize the capability of the designed nanoparticles to display viral glycoproteins, we characterized the structures and antigenic profiles of I53_dn5 fused to the RSV F and influenza HA glycoproteins (DS-Cav1-I53_dn5 and HA-I53_dn5).
Constructs were generated with the two viral glycoproteins fused to the N terminus of the I53_dn5B trimer (sequences in Supplementary Table 9 ), and the proteins were secreted from HEK293F cells and purified by Ni 2+ IMAC. The fusion proteins were mixed with equimolar pentameric I53_dn5A, and the assembly reactions subjected to SEC. For both assemblies, the majority of the material migrated in the peak expected for assembled nanoparticles, and NS-EM analysis showed formation of I53_dn5-like nanoparticles with spikes emanating from the surface ( Supplementary Figures 5 and 6 ). In both cases there was considerable variation in the spike geometry, again suggesting flexibility between the glycoproteins and the underlying particle. The 
Control over BG505 SOSIP Epitope Accessibility using Different Display
Geometries
Because previous work involving icosahedral nanoparticle scaffolds displaying HIV-1 Env trimers has shown that antigen crowding can modulate the accessibility of specific epitopes and thereby influence the humoral immune response 19, 36 , we characterized the antigenicity of the BG505 SOSIP fusion nanoparticles in more detail.
The designed nanoparticle scaffolds developed in this work exhibit varying geometries and valencies, providing a novel way to manipulate epitope accessibility. To determine the effect of particle symmetry/geometry on epitope accessibility, we selected the BG505 SOSIP-T33_dn2 nanoparticle as a candidate to compare against a previously published SOSIP-displaying icosahedral nanoparticle (BG505 SOSIP-I53-50) 19 through surface plasmon resonance (SPR) experiments. To first validate mAb binding to the BG505 SOSIP trimer on a structural level when the latter is fused to the trimeric component T33_dn2A, NS-EM class averages and a 3D reconstruction (see Methods) were carried out with the VRC01 Fab, and the previously observed binding mode was confirmed ( Figure 6a ). Next, a panel of anti-Env mAbs targeting epitopes ranging from the apex to the base of the BG505 SOSIP trimer were immobilized on SPR sensor chips (Figure 6b ).
BG505 SOSIP-T33_dn2A trimer or BG505 SOSIP-T33-dn2 nanoparticle was then flowed over the mAbs and the ratio of macromolecule bound was calculated from the binding signal as previously described 19 . For mAbs that target apical, V3-base, and CD4binding site epitopes (PGT145, PGT122, 2G12, and VRC01), the number of molecules of trimer or nanoparticle bound was relatively similar (ratio ~1). However, for mAbs that target more base-proximate epitopes in the gp120-gp41 interface (ACS202, VRC34, and PGT151), an inter-protomeric gp41 epitope (3BC315), and the main autologous neutralizing Ab epitope in the glycan hole centered on residues 241 and 289 (11B), the accessibility was reduced in the nanoparticle format. Binding to a mAb directed to the trimer base (12N) was obliterated on nanoparticle BG505 SOSIP-T33_dn2 (Figure 6b ).
We also compared this binding to historic data for BG505 SOSIP-I53-50 using six different representative mAbs 19 . As for BG505 SOSIP-T33_dn2, mAbs to the apex, V3base, and CD4-binding site (PGT145, PGT122, and VRC01) gave molar ratios ~1 for BG505 SOSIP-I53-50. However, for mAbs that target the more base-proximate epitopes in the gp120-gp41 interface (VRC34 and PGT151), there was a nearly 3-fold higher epitope accessibility on T33_dn2 than I53-50 nanoparticles (Figure 6c ). Further down the trimer, no accessibility difference was again observed for a mAb that targets the gp41 inter-protomeric epitope (3BC315), which was relatively inaccessible on both nanoparticles, likely due to steric hindrance by neighboring trimers. These findings demonstrate the ability to modulate epitope accessibility by varying the designed scaffold geometry; this capability conferred by the panel of designed nanoparticles could be extremely useful in structure-based approaches to eliciting epitope-targeted humoral immune responses. res. 518-664, 5KAQ res. 11-501, 5TPN res. 27-509) 23, 37, 38 . A C3-symmetric specified docking search was first performed, and output was assessed by the previously described RPX scoring method for symmetric docking 26 . Up to the top-scoring 100 docks for each scaffold were aligned against each of the three immunogens along the shared axis of symmetry and sampled translationally along and rotationally about the axis in 1 Å and 1° increments, respectively. For each sample, the distance between the C terminal residue of the target immunogen and N terminal residue of the docked trimer was measured until a minimum, non-clashing distance was determined (Supplemental Figure 1) . Solutions for docks that were less than or equal to 15 Å for one or more of the three immunogens were selected for full Rosetta symmetric interface design as described in previously published methods 26 . Individual design trajectories were filtered by the following criteria:
Discussion
difference between Rosetta energy of bound (oligomeric) and unbound (monomeric) states less than -30.0 Rosetta energy units, interface surface area greater than 700 Å 2 , Rosetta shape complementarity (sc) greater than 0.65, and less than 50 mutations made from the respective native scaffold. Designs that passed these criteria were manually inspected and refined by single point reversions, and one design per unique docked configuration was added to the set of trimers selected for experimental validation.
Computational Design of Nanoparticles Validated Trimers. Two-component
nanoparticle docks were scored and ranked using the RPX method 26 as opposed to prior methods involving only interface residue contact count 16 . High-scoring and nonredundant nanoparticle configurations were selected for Rosetta interface design with an added caveat that they included trimers with outward-facing N termini for antigen display.
The design protocol took a single-chain input .pdb of each component, and a symmetry definition file 42 containing information for a specified cubic point group symmetry. The oligomers were then aligned to the corresponding symmetry axes of the architecture using the Rosetta SymDofMover, taking into account the rigid body translations and rotations retrieved from the .dok file output from TCdock 16, 17 . Each configuration was then subjected to a symmetric interface design protocol similar to that previously described 26 .
Individual design trajectories were filtered by the following criteria: difference between Rosetta energy of bound and unbound states less than -30.0 Rosetta energy units, interface surface area greater than 700 Å 2 , sc greater than 0.6, and less than 50 mutations made from each native scaffold. Designs that passed these criteria were manually inspected and refined by single point reversions for mutations that did not appear to contribute to stabilizing the bound state of the interface. The sequence with the best overall metrics for each unique docked configuration was then selected for experimental characterization. NS-EM of HA-I53_dn5. The HA-I53_dn5 complex was adsorbed onto glow-discharged carbon-coated copper mesh grids for 60 s, stained with 2% uranyl formate for 30 s, and allowed to air dry. Grids were imaged using the FEI Tecnai Spirit 120 kV electron microscope equipped with a Gatan Ultrascan 4000 CCD Camera. The pixel size at the specimen level was 1.60 Å. Data collection was performed using Leginon 45 with the majority of the data processing carried out in Appion 46 . The parameters of the contrast transfer function (CTF) were estimated using CTFFIND4 47 . All particles were picked in a reference-free manner using DoG Picker 48 . The HA-I53_dn5 particle stack from the micrographs collected was pre-processed in Relion. Reference-free two-dimensional (2D) classification with cryoSPARC was used to select a subset of particles, which were used to generate an initial model using the Ab-Initio reconstruction function in CryoSPARC. The particles from the best class were used for non-uniform refinement in
NS-EM of
CryoSPARC to obtain the final 3D reconstruction. was set with the resulting pixel size of 1.03 Å at the specimen plane. Total dose was set to ~50 e -/Å 2 with 250 ms frames. Nominal defocus range was set to -0.6 to -1.6 µm for all 3 nanoparticle samples. Automated data collection was performed using Leginon software 45 . Data collection information for acquired datasets is shown in Supplementary   Table 5 .
Cryo
Cryo-EM Data Processing. MotionCor2 49 was run to align and dose-weight the movie micrographs. GCTF v1.06 was applied to estimate the CTF parameters. Initial processing was performed in cryoSPARC 2.9.0. Template-picked particles were extracted and subjected to 2D classification. Multiple rounds of heterogeneous refinement were performed to further clean-up particle stacks in 3 acquired datasets. Selected subsets of particles were then transferred to Relion 3.0 31 for further processing. Reference models were generated using Ab-Initio reconstruction in cryoSPARC v2.9.0 50 with the application of appropriate symmetry (tetrahedral, octahedral, and icosahedral for T33_dn10, O43_dn18, and I53_dn5, respectively). Several rounds of 3D classification and refinement were used to sort out a subpopulation of particles that went into the final 3D reconstructions. Tetrahedral, octahedral, and icosahedral symmetry restraints were applied for all 3D refinement and classification steps during the processing of T33_dn10, 
where n is the number of moles of macromolecules, R the response at 300 s (RU), m the mass bound per area and RU (g/(mm 2 RU)), A the interactive area of the chip (mm 2 ), and M the molar mass of the macromolecule (g/mol). This analysis corrects for the greater mass (and thereby greater signal) for each bound nanoparticle such that the number of binding events by differing macromolecules can be directly compared. 
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Structure Deposition Information
Crystal structures have been deposited in the RCSB protein data bank with the PDB IDs 
